Icon

ZYNRELEF KIT (nda211988)- (60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML),200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML),300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML),400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML))

BUPIVACAINE; MELOXICAM HERON THERAPS INC
60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML),200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML),300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML),400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML)
No No
2036-Apr-21 Expired
None 2024-May-12
None No
ZYNRELEF contains bupivacaine, an amide local anesthetic, and meloxicam, a nonsteroidal anti-inflammatory drug (NSAID), and is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.
0 0 0
Total Other Developers None
Drugs with Suitability No
60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) ** ** - - -
200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) ** ** - - -
300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) ** ** - - -
400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.